Recent work

Get an impression of some of my recent projects to learn more about my experience and expertise.

Strategy and writing of reimbursement dossiers (Several Pharma and Biotech clients)

Q4 2023- ongoing

Client requested support in both strategy as well as composing dossiers to obtain reimbursement for their therapeutic products. Valence analyzed the available data and substantiation for a dossier, identified potential reimbursement routes with opportunities and consequences, composed dossiers, supported communication during the reimbursement evaluations and negotiations, managed alignment meetings, and ensured access for valuable products.

Expert for evaluation (Dutch government)

Q1 2025-ongoing

Client requested Valence as independent expert for evaluation of conditional authorization processes. Am supporting a consulting agency with critical input in stakeholder interviews and am providing expertise on Dutch reimbursement processes.

Strategic support for study design (TOP10 Pharma)

Q3 2024- Q4 2024

The client requested support for future reimbursement trajectories in Europe. Valence informed on improvements and potential challenges regarding future Joint Clinical Assessment submissions and provided strategic advice on how best to adhere to European requirements. Study designs were adapted accordingly.

Waiting times for medical appointments (Patient federation)

Q2 2023 – Q1 2024

Client requested support in the development of insights in patient waiting times. The assignment consisted out of improving current display and setting up research for further improvements. Execution involved aligning with multiple stakeholders (including government), focus groups, and guiding research and online communication.

Organizing event for medical practices (Patient federation)

Q3 2023 – Q1 2024

Client requested support in organizing an event for medical practices that were highly appreciated by patients. The event was initially a symposium which changed to a national tour to reach more health care staff. Communication and marketing activities were performed in collaboration.

Advisory boards and Consultations for consultancies and firms in the medical field

Q3 2023 – ongoing

Requests for mock HTA negotiations, feedback on messaging, and support in understanding the Market Access landscape, constraints and opportunities.

What clients say…

"I would like to share my experience with the services of Caroline (Valence consultancy), as this collaboration has had a tremendously positive impact on my project and goals.

Before I decided to work with Caroline, I was in a situation where I lacked the necessary expertise and guidance to achieve the desired results, which led to delays and frustrations.

What won me over to work with Caroline was the compelling feedback and recommendations from previous clients. The expertise demonstrated in the initial conversations gave me confidence that I was partnering with the right partner.

My first impression of Caroline's services was extremely positive. From the first contact, I felt a high level of professionalism and commitment. Caroline really takes the lead and also guides international colleagues through the process. As a result, the entire project has a clear, structured approach with ditto timelines.

Caroline helped me to achieve my goals by being very meticulous and    collaborating with various parties to compile the dossier which led to a positive advice from the Dutch HealthCare Institute. Regular updates and transparent communication ensured that I was always aware of progress and any issues were resolved quickly.

I can highly recommend her if you have issues regarding reimbursement files or other MA challenges."

General manager
Biotech company

"Valence Consultancy’s creativity results in out of the box solutions for our reimbursement challenges.I am very happy to work with her."

Market Access Manager
Pharmaceutical Company

"It is a pleasure to work with Valence Consultancy on payer evidence strategy - Caroline is Professional , highly experienced and responsive. She is also thoughtful and provide valuable additional insights and opinions."

Market Access Executive director
top 10 pharma

Contact

successful

Message sent! Thank you. We will GET BACK as soon as possible.

An error has occurred somewhere and it is not possible to submit the form. Please try again later or contact us via email.